FDA issues warning about on-line counterfeiters

May 7, 2007

The FDA has issued a warning about the sale of counterfeit prescription medications from on-line pharmacies.

The FDA has issued a warning about the sale of counterfeit prescription medications from on-line pharmacies. The warning came as a result of an investigation by pharmaceutical manufacturer Hoffmann-La Roche, which found its weight-loss drug Xenical being sold without the active ingredient orlistat. Some of the capsules contained instead sibutramine, the active ingredient of Meridia (Abbott), while others were composed of only talc and starch. According to Roche, some samples displayed a valid lot number but had an incorrect expiration date. The FDA attributed the counterfeit medications to Web sites run by pharmacycall365.com, which has been previously identified as a distributor of counterfeit Tamiflu (oseltamivir, Hoffmann-La Roche) and Cialis (tadalafil, Lilly ICOS).

 

To see more Hot off the Press news articles, click here.

To go to the Drug Topics homepage, click here.

Related Content:

Community Practice | News